FDA clears Alpha Tau to double enrollment in glioblastoma trial

October 19, 2026 8:30 AM

Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) announced that the U.S. Food and Drug Administration has approved an Investigational Device ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found